ArticleHeart and vessels2021

Ischemic stroke, hemorrhage, and mortality in patients with non-valvular atrial fibrillation and renal dysfunction treated with rivaroxaban: sub-analysis of the EXPAND study.

Hirotsugu Atarashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.